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INTRODUCTION
The winter issue of the MCV QUARTERLY
presents a departure from our usual symposium proceedings. We offer, instead, five full-length articles
and two case reports that range from respiratory
fai lure and the dental health of pre-Columbian
Peruvians to a report of a rare clinical entity, an
intrapulmonary lymph node presenting as a 'coin'
lesion. We hope that our readers will find these
papers interesting and informative.
THE EDITORS

Respiratory Therapy Modalities in the
Treatment of Acute Respiratory Failure
JAMES A. L. MATHERS, JR., M.D.
Assistant Professor of Medicine and Co-M edicaf Director, Respiratory Therapy, Medical College of Virginia,
Health Sciences Division of Virginia Commonwealth University, Richmond, Virginia

Rapid advances have been made in the field of
respiratory therapy in the past several years, resulting
in an increasing sophistication and range of application . Properly applied, these modalities have led to
significantly increased survival in patients with acute
respiratory failure and a decreased morbidity among
individuals with chronic pulmonary insufficiency . It
is the purpose of this article to put into perspective
respiratory therapy techniques and their application
in the treatment of acute respiratory failure. To this
end, we may divide respiratory therapy into five categories: I) oxygen delivery, 2) airway hygiene, 3) expansion therapy (lung inflation), 4) artificial airways,
and 5) mechanical ventilation.
While the symptoms are not specific, the onset of
acute respiratory failure is not a subtle event. Abnormal arterial blood gases are invariably present. Indeed, the entity is usually defined in terms of the
degree of alteration in the arterial blood gases. Acute
respiratory failure results from one of three general
abnormalities: I) neuromuscular dysfunction, 2) increased airway resistance, and 3) reduction of pulmonary compliance. In pure form each of these categories produces a predictable pattern of arterial
blood gas derangement. Rational management of
acute respiratory failure requires an awareness of
these alterations so that the respiratory therapy may

This is a review of respiratory th erapy modalities as they are
currently used a t the Medica l College of Virgini a .
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be intelligently applied to stabilize or reverse the patient's pulmonary deterioration.
In the initial assessment of the patient in acute
respiratory distress, it is important to determine the
nature of the respiratory compromise. Patients with
neuromuscular dysfunction such as occurs with drug
overdose or Guillain-Barre syndrome may have normal lungs but do not have the ability to maintain an
adequate minute ventilation . The arterial blood gas
derangement consists of hypoxemia and relatively
acute hypercarbia with a normal alveolar-arterial oxygen tension gradient. Respiratory failure due to a
sudden increase in airway resistance includes entities
such as status asthmaticus, or bronchospasm with
retained secretions in patients with underlying
chronic airway disease. The arterial blood gas analysis will reveal hypoxemia with hypercarbia and a
widened alveolar-arterial oxygen tension gradient.
The functional residual capacity is elevated and , in
many patients, there is actually an increase in pulmonary compliance. The gas exchange abnormality
results from ventilation-perfusion mismatching. Patients whose respiratory failure results from an acute
loss of pulmonary compliance are those with an overwhelming parenchymal insult such as occurs with
extensive bacterial pneumonia, aspiration, or a systemic process such as pancreatitis. These disorders
may be grouped under the heading of adult respiratory distress syndrome. The physiologic alterations
are hypoxemia with hypocarbia and respiratory alkalosis because of right-to-left shunting of blood, a fall
in the pulmonary compliance, and a marked reduction in the functional residual capacity .
159
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Hypoxemic Hypercapneic Respiratory Failure with
Normal A-a 0 2 Gradient
The Respiratory Therapy Department of an institution becomes involved with these patients when
the decision has been made to institute mechanical
ventilation. While the initial selection of artificial airways is not in the domain of this department, usually
it is the respiratory therapists who are called upon
when these airways do not function properly. Because of the experience gained in managing airway
problems, we at the Medical College of Virginia have
developed a number of recommendations for this
aspect of respiratory care. When selecting an artificial
airway, one must make an initial decision between
"compliant" and "stiff" cuffs. We prefer to use the
large volume compliant cuff tubes because a seal is
obtained at a lower cuff pressure. Furthermore, the
intracuff pressure measured by the respiratory therapist is a more accurate assessment of pressure exerted
against the tracheal wall than pressures obtained
from stiff cuffs.
While orotracheal tubes may be rapidly inserted
during an emergency such as a drug overdose, these
tubes are associated with the highest incidence of
tracheal damage since they are difficult to stabilize
and have a tendency to move about in the trachea
when the r:>atient is turned, m_oves or coughs. Nasotracheal tubes are more stable and, when a compliant cuffed tube is placed via this route, they may be
left in place for as long as two to three weeks with a
minimum of tracheal damage. The cross-sectional
diameter of the nasotracheal tube is smaller than the
orotracheal tube. The combination of longer length
and the narrow diameter may make adequate suctioning difficult. Should the management of secretions be a problem and a prolonged intubation anticipated, elective tracheostomy offers many advantages
such as the wide variety of tubes available, including
talking tracheostomy tubes, fenestrated tubes, and
cuffiess tubes; patients may be fed via the oral route;
vocal cords are not damaged ; and there is no damage
to the nasal septum. With the advent of the compliant
cuff and better management of the artificial airway,
the incidence of tracheal damage has decreased significantly. It does occur from time to time, however,
and we stress the importance of periodic monitoring
of intracuff pressure.
When the decision has been made to intubate
patients with this form of respiratory failure, and the
appropriate airway has been selected, mechanical
ventilation is usually instituted with relative ease be·
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cause of the normal physiology of the underlying
lung.

Hypoxemic Hypercapneic Respiratory Failure with
Abnormal A-a 0 2 Gradient
This disturbance is most frequently found in patients with increased airway resistance due to bronchospasm, obstructing secretions, and mucosa] swelling and edema. The immediate approach to the
hypoxemic patient is to stabilize the arterial oxygen
tension while treating the underlying defect in hopes
of avoiding intubation. The goal is to maintain the
Pao 2 in the range of 60 to 80 mm Hg which will insure
hemoglobin saturation in excess of 90%. Further increases in the arterial oxygen tension do not significantly increase oxygen delivery to the tissues. The
mode of oxygen administration is of great importance in the presence of hypercapnia. Oxygen therapy
devices are divided into high-flow or low-flow systems. A high-flow apparatus mixes oxygen and room
air prior to delivery to the patient. The gas flow
delivered by the device is sufficient to provide the
patient's total minute ventilation. Low-flow systems
do not provide enough gas flow to supply the entire
inspired atmosphere, and some part of the tidal volume will be supplied by the entrainment of room air.
Such systems may provide any concentration of oxygen from 21 % to 95%, but the fraction of inspired
oxygen (F 10 2 ) can be altered by the patient's respiratory pattern. Low-flow devices include the nasal
cannula and mask oxygen and may be used when the
tidal volume of the patient is between 300 and 700 cc,
the ventilatory rate is less than 30/ min, and there is
relatively stable ventilatory pattern with time. Because of the potential danger of excess oxygen administration, we prefer to keep the F 10 2 as low as is
consistent with adequate oxygen delivery to the tissues. The unpredictability of the tidal volume and
minute ventilation in an acutely ill patient are reasons
why we generally recommend high-flow oxygen systems; the most commonly used of these are masks
that work on the Venturi principle. The standard
inspired 0 2 fractions available are 24%, 28%, 35%,
and 40%. Humidifiers are not required with these
masks because the major portion of inspired gas is
room air. To supply a high flow of oxygen in excess of
40%, special systems can be a rranged by the Respiratory Therapy Department.
The importance of the mucociliary escalator in
maintaining airway homeostasis is often underestimated. If the mucous blanket becomes dry or
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abnormally thick, secretions . will not mobilize normally and cough will become ineffective, leading to
dramatic increases in airway resistance. The most
effective means of reestablishing the mucous blanket
is to hydrate the tracheobronchial tree. Water may be
delivered to the airway in molecular form as humidification or in particulate form as an aerosol. Simple
bubble-type humidifiers are sufficient for patients
with an intact upper airway. Should the nasopharynx
be bypassed by an artificial airway, a heater is added
to the humidifier to further increase water content. If
one wishes to deliver particulate water or medications
to aid bronchial hygiene, a nebulizing device should
be used. Ultrasonic nebulizers produce a very heavy
water mist with uniform particle size on the order of
.5µ, to 3µ,. Jet nebulizers, which operate on the Bernoulli principle, may be used for aerosolization of
both water and medications. Droplets are propelled
against baffles which eliminate the larger and heavier
particles since droplets of greater than IOµ, in size are
clinically useless as they dci not deposit in the
tracheobronchial tree. Aerosolized medications include mucolytics, bronchodilators, vasoconstrictors,
and steroids. In addition to instillation of water into
the airway, efforts have been made to change the
viscosity of the secretions by nebulizing sodium bicarbonate or acetylcysteine. Usually these agents are
no better at mobilizing dried secretions than good
hydration ; however, in circumstances where the
mucous is abnormal, such as cystic fibrosis, they may
be useful. They may also be successfully used in those
patients where active oral or intravenous hydration is
not practical or safe. Inhaled bronchodilators exert
their effect following absorption into the circulation.
Absorption from the pulmonary system is rapid and
the degree of bronchodilation obtained will be equal
to that of an intravenous dose with similar blood
levels. Vasoconstrictors may be administered by
aerosol primarily for their topical properties. Many
acute pulmonary diseases a re accompanied by an
inflammatory reaction of the respiratory mucosa
which includes profound capillary congestion and
swelling. Topical application of a vasoconstrictor
may have dramatic effects in decreasing the hyperemia and increasing lumen size. Racemic epinephrine
is a very effective topical vasoconstrictor and a mild
systemic bronchodilator. It may be of significant benefit as adjunctive t~erapy to intravenous theophylline. Choice of nebulizing devices for any of these
medications should be made by assessing the patient's clinical status and the ability of the patient to
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generate adequate tidal volumes. We prefer that a
hand-held nebulizer be used since these devices are
inexpensive and are powered from a readily available
compressed air source. There is evidence of improved
distribution of particles when spontaneous inspiration is used with these nebulizers in contrast to
medication delivered via intermittent positive pressure breathing (I PPB). These attempts at reducing
airway resistance may be applied in conjunction with
"expansion " therapy. Incentive spirometry appears
to be superior to IPPB for preventing and treating
atelectasis .
Despite the a bove measures (controlled oxygen
administration, aerosolized medications, aggressive
management of secretions, and expansion therapy) a
number of patients with acute respiratory failure due
to increased airway resistance will require intubation
and mechanical ventilation. A volume-cycled ventilator is the modality of choice in acute respiratory
failure. We follow the usual guidelines of 15 cc tidal
volume/ kg of body weight, respiratory rate of 15
times per minute and F 10 2 of 40% for initial setting.
Twenty minutes to a half hour after beginning mechanical ventilation, the arterial blood gases are repeated and adjustments are made as necessary. Because the basic problem with these patients is varying
degrees o f a irway resistance in different areas of the
lung, it is advisable to use as low an inspiratory flow
rate as is consistent with the patient's ventilatory
pattern . This promotes gas delivery to poorly ventilated regions rather than over-expansion of well-ventilated regions. It is also important to provide for
sufficient expiratory time. If too short a period is
allowed for expiration, hyperinfl ation of the patient's
lungs beca use of gas trapping may result. A most
useful r.ecent addition to our therapeutic techniques is
intermittent mandatory ventilation (IMV). A circuit
of constant gas flow is added in parallel to the patient's ventilator allowing the patient to breathe
spontaneously at his or her own tidal volume between
pre-set breaths delivered by the volume ventilator.
This system minimizes the possibility of excessive
mechanical ventilation and allows better acid-base
control. As the patient's clinical condition improves,
the respirator rate may be gradually reduced, promoting a smoother weaning period . Complications
that may develop in patients on ventilators include
atelectasis in poorly ventilated areas, pneumot)lorax,
superinfection, or drying of secretions with mucous
plugging if the inspired atmosphere is not properly
humidified .
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Hypoxemic Hypocapneic Respiratory Failure
This blood gas pattern is found in syndromes in
which the pulmonary parenchyma has been damaged. The severity of the condition will be apparent
when there is a minimal increase in arterial oxygen
tension in response. to an F 10 2 of .4 or above. This
documents the presence of right-to-left shunting of
blood. The reduction of parenchymal compliance in
these patients makes the selection of tidal volumes
more complex than in those with obstructive problems. The pressure volume curve of the respiratory
system may be determined at the time the patient is
placed on mechanical ventilation. We are often able
to identify a point in the curve above which a slight
increase in tidal volume produces a dramatic increase
in intrathoracic pressure. This may occur at a tidal
volume as low as .7 liters. If one arbitrarily applies
the rule of 15 cc/ kg to these patients, the thoracic
capacity may be exceeded and there will be
inappropriately high intrathoracic pressure relative tp
the effective tidal volume. An appropriate minute
ventilation may be delivered by reducing the tidal
volume and increasing the rate of ventilation. This
will reduce mean intrathoracic pressure and reduce
the incidence of barotrauma.
Most patients in this category who are gravely ill
will remain hypoxemic despite the increased F 10 2
and mechanical ventilation. These modalities do not

an

reverse the primary defect of reduced Functional Residual Capacity. This problem may be partially corrected by increasing the distending pressure within
the thorax. This is done by applying positive end
expiratory pressure (PEEP): Com'plications include a
reduction in cardiac output and pneumothorax. ·It
should be noted, however, that the occurrence of
pneumothorax is related to the level of mean intrathoracic pressure during mechanical ventilation and
not to the presence or absence of PEEP.
In . summary, respiratory therapy should be
thought of as a series of specific steps designed to
treat the anatomic and physiologic alterations that
occur with the various forms of respiratory failure,
The scientific basis of the field is rapidly advancing as
more is learned about the mechanisms of pulmonary
disease. Respiratory therapy should no longer be
equated solely with IPPB but should be regarded as a
field encompassing a number of effective treatment
modalities.
Suggestions for further reading
I. BURTON GG, GEE GN , HODGKIN JE: Respiratory Care: A guide
to Clinical Practice. New York'. JB Lippincott Company, 1977.

2. HEDLEY-WHITE J, BURGESS GE, F EELEY TW, ET AL: Applied
Physiology of Respirqtory Care. Boston, Little, Brown and
Company, 1976.

Screening Pulmonary Function Tests
GEORGE W. BURKE, III, M.D.

Assistant Professor of Medicine, and Director, Pulmonary Function Laboratories, Medical College of Virginia,
Health Sciences Division of Virginia Commonwealth University, Richmond, Virginia

The role of the Pulmonary Function Laboratory
has been expanded in recent years by the commercial
development and marketing of equipment capable of
measuring accurately and easily static lung volumes,
diffusing capacity, and arterial blood gases. These
sophisticated measurements, which were once the
purview of research physiologists, are now readily
attainable as screening measurements in most comm unity hospitals. This review is intended not as a
summary of the entire field or as a technical guide for
performance of pulmonary function tests but as a
survey of some clinical applications and pitfalls of
screening tests and a statement of guidelines for their
use. It is assumed that the reader already has some
experience in ordering and interpreting routine spirograms and arterial blood gases.
Pulmonary function tests are intended to answer
four questions:
1) Is the patient restricted?
2) Is the patient obstructed?
3) Does the patient have abnormalities of gas
exchange?
4) Are the observed abnormalities compatible
with the patient's symptoms and clinical diagnosis?
Restriction is a reduction of total lung capacity
or one of its subvolumes (Fig I) as a result of collapse
or volume displacement of the lung (fibrothorax), increased elastic recoil of the lungs (pulmonary fibrosis), increased elastic recoil of the rib cage or abdomen (obesity), or loss of forces needed to overcome
normal elastic recoil (muscular dystrophy) . It is im-
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portant to realize that a routine spirometric vital
capacity measurement may not adequately describe
the presence or degree of restriction. For example,
some patients with advanced emphysema may have
reduced vital capacity in the face of a large residual
volume, with increased total lung capacity caused by
obstructive air trapping; it is misleading to label such
patients as "restricted" on the basis of reduced vital
capacity when, in fact, they are overinflated. On the
other hand, true early restriction may occur in the
face of normal vital capacity. An example of this is
obesity, a condition in which the abdominal mass
renders the chest wall less compliant by hindering
downward displacement of the diaphragm. The
earliest change in the restrictive pattern of obesity is a
marked reduction in expiratory reserve volume
(ERV) (see Fig I) but only minor alterat.ions of the
total lung and vital capacities. Therefore, accurate
evaluation of patients with suspected restrictive disorders should include, in addition to routine spirometry, a measurement of total lung capacity and its
subdivisions by inert gas or plethysmographic techniques. The following case illustrates the use of pulmonary function studies in following the course of a
restrictive lung disorder:
Case I. A 53-year-old white woman developed exertional
dyspnea and cough in 1971. A chest roentgenogram revealed bilateral basilar "ground-glass" opacities. In April
1972, an open lung biopsy showed desquamative interstitial
pneumonia. She was placed on 20 mg prednisone daily in
August 1972, and sequential pulmonary function tests were
performed (Table I). The initial vital and total lung capacities were consistent with moderately severe restriction, and
there was a correspondingly severe reduction in diffusing
capacity. After two years of prednisone therapy, these abnormalities improved substantially (October 1974). When
steroids were stopped she experienced a severe relapse
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(February 1976) which was reversed by their resumption
(February 1977). In 1977 she was in remission while taking
20 mg prednisone on alternate days.. The pulmonary function studies provided quantitative objective evidence that a
prolonged course of steroid therapy was necessary.

Obstructive impairment, defined as a reduction
in inspiratory or expiratory air-flow rates, is a result
of intrinsic airway disease or loss of lung elastic recoil. The latter causes airways to lose their structural
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Fig 1-Spirogram with various subdivisions of total lung capacity.
Initial deflections at left are tidal volumes recorded on slowly
moving recording paper. Large deflection upward is inspiration to
total lung capacity, followed by expiration to residual volume and
resumption of tidal breathing. Residual volume is not measured
directly, but has been previously determined by inert gas study.
Time is on the horizontal axis, volume on the vertical.

support. Intrinsic airway disease may be caused by a
variety of conditions ranging from totally reversible
asthmatic bronchoconstriction to irreversible advanced chronic bronchitis with bronchiolitis obliterans. Loss of elastic recoil almost always is a result of
localized or generalized emphysema.
Because the conditions causing airways obstruction tend to become more exaggerated during forced
expiration (during which alveoli and airways are rapidly diminishing in both length and diameter), the
conventional method of assessing obstructive impairment is by measuring averaged flow rates on a volume-time curve of an ordinary spirogram during a
maximally forced expiration of the vital capacity.
(Fig 2). Although one could arbitrarily measure flow
at a multitude of points on the curve, three measurements have been standardized and used most frequently (see Fig 2): the timed vital capacity (FEY,);
the ratio of FEY, to total vital capacity; and the
maximum mid-expiratory flow rate (MMEF) (the averaged flow over the mid-half of the vital capacity).
Ordinarily all three measurements are made and abnormalities of one tend to correlate with those of the
others. Additional measurements such as peak flow,
total expiratory time, and forced expiratory volume
in three seconds, or "FEY 3 ," add little new information but may be sensitive indicators of changes wheri.
evaluating drug effects in population samples.
Obstruction is conventionally quantitated during expiration; however, patients develop dyspnea
from obstructive impairment because of the increased
work of breathing during inspiration. In most cases,
obstruction during inspiration is inferred by abnormalities in the FEY, and MMEF; unfortunately,
there are several important exceptions to this. Individuals with obstruction isolated to the trachea or
larynx (for example, tracheomalacia following endotracheal intubation) may not have evidence of exTABLE 1
Sequential Function Studies in a Patient with Desquamative
Interstitial Pneumonia.
August October February February Pre1972
1974
1976
1977 dieted
Vital capacity,
liters
2.06
Total lung
capacity,
liters
3.55
Arterial Po,,
torr
66
Diffusing capacity,
ml/ min/ torr
8.5

3.45

2.30

3.12

3.97

5.24

3.79

4.95

6.32

73

67

76

90

17.0

7.9

11 .2

22.0
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Fig 2-Forced vital capacity shown on rapidly moving recording
paper. Total downward excursion of curve (vertical axis) is vital
capacity. Volume exhaled during the first second is FEY,. MMEF
is slope of line connecting points A and B. Time is on the horizontal axis.

piratory obstruction if their defect is above the thoracic outlet, or they may have spirometric
abnorma lities which are misinterpreted as generalized airways obstruction if their defect is below the
thoracic outlet. In addition, individuals with substantial narrowing of bronchioles but normal patency
of bronchi (for examp le, young smokers with early
chronic bronchitis) may have completely normal
spirometric flow rates but isolated abnormalities of
MM EF which are difficult to interpret because of the
large standard deviation of this test in the normal
population.
When either of these exceptions is suspected,
additiona l information may be obtained by a recording of a flow-volume curve, or graphical representation of instantaneous mouth flow and expired volume
during a forced inspiration and expiration of the vital
capacity (Fig 3 ). The normal configuration of this
curve is shown in Figure 3a. Fixed obstruction in the
trachea produces a characteristic fixed limitation to
flow which is independent of volume (Fig 3b ). An
additional advantage of the flow-volume curve is its
depiction of inspiratory events, thus facilitating the
detection of variable extrathoracic upper-airway obstruction (Fig 3c ). Generalized bronchiolar narrowing produces flow limitations which are detectable
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Fig 3a-I nspiratory-expiratory flow-volume curve shows normal
configuration in a 28-year-old man .
Fig 3b-Fixed upper-airway obstruction seen in a 32-year-old man
with stenosis of intrathoracic trachea.
Fig Jc-Curve shows variable extrathoracic obstruction as a result
of loss of cartilagenous tracheal support in the subg lotti c region.
The weakened area collapses on inspiration but is distended during
expiration by positive airway pressure.
Fig 3d-"I nwardly concave" distortion of the expired curve at
lower lung volumes is seen in a 30-year-old chronic cigarette
smoker with a normal spirograni. The distortion is due to
bronchiolar obstruction.

only on expiration at lower lung volumes and tend to
worsen as volume diminishes. This will result in an
"inwardly concave" appearance to the flow-volume
curve in patients with obstruction limited to the bronchioles (Fig 3d). It should be pointed out that this
"inwardly concave" configuration is not specific for
peripheral small airways obstruction; if the spirogram also indicates obstruction, the curve is not use-
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fut for differentiating generalized obstruction from
that isolated to peripheral airways. The following
case is an example of obstructive impairment and
also illustrates the value of lung volume determinations by the helium dilutional method in differentiating obstructive from restrictive impairment:
Case 2. A 19-year-old male gas station attendant abruptly
developed exertional dyspnea in January 1976. Seven
months later a carefully taken history revealed that he had
been caring for his brother's homing pigeons since late
December 1975. The ·c hest roentgenogram was normal ,
although symptoms persisted. Pulmonary function studies
(Table 2, July 1976) revealed a reduced vital capacity;
however, the total lung capacity and residual volume suggested probable obstructive air trapping rather than restriction. The FEV 1 and MMEF confirmed obstruction. With-

out specific treatment other than ceasing the pigeon
exposure, his symptoms resolved and objective improvement
was evident on sequential studies (September 1976). Although both restriction and obstruction may occur in a llergic alveolitis, restriction is usually the dominant impairment. However, in this patient 's case, obstruction occurred
without restriction.

Arterial hypoxemia is a sequela of impaired gas
exchange; however, measurement of resting arterial
oxygen tension (Po 2) alone may not be sufficiently
sensitive to detect such impairment. Impaired gas
exchange is also present if there is an increase in the
observed oxygen tension difference between alveolar
air and arterial blood (DA-a 0 2) or if there is an
abnormality in the diffusing capacity for carbon
monoxide. For ambulatory patients breathing room
air, DA-a 0 2 can be estimated by obtaining a sample
of arterial blood under steady-state conditions. Alveolar oxygen tension is calculated by the standard
alveolar air equation:
PA02

0°

= F102(713) = Paco2 (F 10 2 + 1 - ; 2)

F 102 = fraction of02 in inspired air
arterial Pco 2 (identical to mean alveolar
Pco2)

Paco 2
RQ

=

respiratory quotient

The achievement of steady-state conditions is an essential prerequisite for this test because the estimation of alveolar oxygen tension is based on the assumption that the ratio of C0 2 produced to 0 2
consumed (RQ) is 0.8. Transient hyperventilation
caused by anxiety or pain will invalidate this assumption. Direct measurement of RQ may provide a more

TABLE 2
Sequential Function Studies in a Patient with Allergic Alveolitis Due to Pigeon Exposure.

Vital capacity,
liters
Total lung
capacity, liters
Residual volume,
liters
FEY,, liters
FEV 1 / Vital
Capacity,%
MMEF, liters/sec.

July
1976

September
1976

Predicted

3.98

4.42

5.62

6.95

6.68

7.34

2.97
2.51

2.26
3.09

1.72
4.54

63
1.24

70
2.03

80
4.90

refined estimation of PA 0 2; however, this also requires sampling under steady-state conditions. For
either approach, hyperventilation may be avoided by
inserting an arterial cannula and allowing the patient
to rest prior to sample collection.
The measurement of carbon monoxide diffusing
capacity by the simplified single-breath technique requires the patient to breath hold at total lung capacity
for ten seconds. Patients who are markedly dyspneic
at rest may not be able to perform this test. Despite
these limitations, useful results are forthcoming for
most cooperative subjects.
The precise pathophysiologic explanation for
impaired diffusion of carbon monoxide in lung diseases is unknown. Most authorities agree that it is a
sign of alveolar or capillary destruction. Therefore,
impaired CO uptake may occur in parenchymal destructive processes such as idiopathic fibrosing alveolitis, scleroderma, advanced sarcoidosis, and in
vascular obliterative processes such as idiopathic pulmonary hypertension or multiple small pulmonary
emboli. It is also impaired in processes causing reversible loss of functioning alveoli, examples of which
are bacterial pneumonia and alveolar proteinosis. CO
uptake is impaired in generalized emphysema due to
emphysematous destruction of alveoli but remains.
nearly normal in chronic bronchitis because the destructive process is confined to airways and centrilobular elements of the parenchyma. Diffusing capacity may be spuriously impaired by several conditions.
The first is the presence of severe anemia, which
limits the availability of hemoglobin CO receptors;
the second is that failure to achieve true total lung
capacity during the breathhold will reduce CO uptake in proportion to the reduction in potential lung
volume. The following case illustrates the value of the
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0 2 were also normal. However, a moderately severe reduction in diffusing capacity suggested the presence of widespread interstitial disease despite the clear roentgenographic
lung fields. Hemoglobin was normal. A transbronchoscopic
lung biopsy showed interstitial non-caseating granulomata
consistent with sarcoidosis.

TABLE 3
Pulmonary Function Studies in a Patient with Sarcoidosis
Vital capacity, liters
FEY" liters
FEY/vital
capacity,%
MMEF,
liters/second
Total lung capacity,
liters
Residual volume,
liters
Pao,, torr
DA-a 0 2 , torr
Diffusing capacity,
ml/ min/ torr

September 1978
2.98
2.68

Predicted
3.63
2.88

90

79

4.03

3.37

3.85

5.12

.76
92
13

1.49
90
15

12.0

21.7

diffusing capacity in screening patients for the presence of gas exchange impairment:
Cas~ 3. A 32-year-old woman complained of mild exertional dyspnea of two months duration. Chest roentgenogram revealed bilateral hilar adenopathy. Pulmonary function studies (Table 3) showed a modest reduction in total
lung capacity (75% predicted) with normal vital capacity
anq flow rates. Resting arterial oxygen tension and DA-a

Although measured impairment in pulmonary
function frequently provides an objective explanation
for the presence of dyspnea, many patients may experience this symptom because of abnormalities which
are undetectable on screening evaluations. Negative
screening studies should stimulate a careful search for
vascular disease or nonpulmonary causes of dyspnea.
For example, "metabolically justified" hyperpnea
and dyspnea may accompany hyperthyroidism; patients with mitral stenosis or early congestive heart
failure may have only mild impairment in lung mechanics despite severe exertional dyspnea; and patients with partial obliteration of the pulmonary vasculature may have normal lung mechanics, arterial
oxygen tensions, and diffusing capacities while at
rest, only to show abnormalities during exercise.
For a variety of vascular and interstitial pulmonary disorders, it may be appropriate to evaluate

TABLE 4
Guidelines for Ordering Medical or Surgical Screening Pulmonary Function Studies.
1. Asymptomatic non-smoker

No studies; " routine spirogram" (vital capacity, FEY" MMEF) if thoracic
surgery is planned.

2. Asymptomatic smoker

Routine spirogram; add resting arterial blood gases if t horacic surgery is
planned.

3. Heavy smoker with dyspnea and/ or chronic bronchitis

Routine spirogram; total lung capacity; diffusing capacity; resting arterial
blood gases.

4. Young asthmatic

Spirogram before and after an inha led bronchodilator.

5. "Old" asthmatic (> 30 years)

Spirogram before and after inhaled bronchodilator; tota l lung capacity: resting
arterial blood gases.

6. Suspected tracheal obstruction, stridor, or unexplained obstruction on a previous spirogram

lnspiratory and expiratory flow- volu me curve.

7. Suspected interstitial lung disease

Spirogram; total lung capacity; diffusing capacity; steady-state arteria l blood
gases with DA-a 0 2 •

8. Suspected pulmonary vascular disease

Same as #7. Add exercise DA-a 0 2 , physiologic deadspace, end tidal CO,
gradient.

9. Suspected a natomic right-to-left shunt

Arterial blood gases while breathing I00% 0,. This st udy should never be
requested for patients with emphysema or chronic bronchitis who have CO,
retention .

10. Suspected early small-airways disease

In view of the limited clinical benefits, adequate evaluation is too expensi ve.
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physiology during exercise as resting abnormalities
frequently are exaggerated during exercise. However,
pulmonary exercise testing, unlike cardiac stress testing, should provide a graded low level of exercise
(doubling or tripling of the oxygen uptake) rather
tha n maximum stress. In fact, recent experimental
evidence' has suggested that maximum stress measurements are potentially misleading because normal
subjects may demonstrate transient abnormalities in
Pao 2 and DA-a 0 2 while performing temporary but
severe tasks such as rapid stair-climbing. Although a
complete discussion of exercise physiology testing is
beyond the scope of this paper, som'e recent reviews
of the relevance of pulmonary exercise testing in clinical medicine are included in the bibliography.1-2
Table 4 is a suggested modus operandi for ordering screening pulmonary function studies for specific
problems. Physicians ordering such tests must realize
that measurements of lung mechanics require both
cooperation ard effort. Too much testing at a sing!~
sitting may fatigue the patient and cause spuriously

abnormal results. For example, it would be unwise to
subject a patient to both screening studies and exercise physiology studies for suspected vascular disease
on the same day . Therefore, in the context of the
suggestions in Table 4, clinical wisdom and common
sense should dictate which tests are appropriate for
individual patients. ·
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Flexible Fiberoptic Bronchoscopy
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The flexible fiberoptic bronchoscope was introduced in Japan by Dr. Shigeto Ikeda in the midI 960s and became available .for clinical use in the
United States around i 970. The application of this
technique represents one of the most significant advances for the diagnosis and management of chest
diseases as it enables the physician to directly visualize the tracheobronchial tree and obtain diagnostiC
specimens from regions of the lung previously inaccessible to the rigid bronchoscope. Except for subpleural lesions, fiberoptic bronchoscopy is the surgical procedure of choice in the evaluation of many
pulmonary lesions.' In addition, fiberoptic bronchoscopy plays a major therapeutic role in the evaluation of airway patency and elimination of retained
secretions.
The new Olympus® (BF-IT), Machida® (FBS6TL; FBS-6TL II), and Pen tax® (FB- I 9A) fiberoptic
bronchoscopes have larger channels measuring 2.6
mm in diameter as compared with older inodels
whose channels measure 1.8 to 2.2 mm. These larger
channels provide more effective suctioning and larger
biopsy specimens. 2

Indications for Fiberoptic Bronchoscopy
The following are accepted indications for fiberoptic bronchoscopy:
1. Any pulmonary lesion of uncertain nature.
Subpleural lesions are exceptions.
2. Retained bronchial secretions
3. Evaluation of airway patency
4. Miscella neous:
a. hemoptysis in a patient with a normal
chest radiograph
Correspondence and reprint requests to Dr. Orhan Muren,
Box 914, Medical College of Virginia, Richmo nd, VA 23298.
MCV QUARTERLY 14(4):169-171 , 1978

b. positive sputum cytology (that is, cancer)
in a patient with normal chest radiograph
c. small, peripheral foreign bodies in adults
d. patients with trauma or disease affecting
the cervical spine or jaw
e. patients on mechanical ventilators
Rigid bronchoscopy is preferred in the following
situations:
I . Severe pulmonary hemorrhage
2. Centrally located foreign bodies
3. Children requiring bronchoscopy
4. Tracheal stenosis, secondary to intrinsic or
extrinsic lesions

Risks and Contraindications
The following conditions are associated with increased risks during or following fiberoptic bronchoscopy:3
I. Hemoptysis (increased incidence of postbronchoscopy bleeding)
2. Bronchial asthma (danger of severe bronchospasm)
3. Uremia (danger of severe hemorrhage after
biopsy)
4. Immunosuppression (hazard of post-bronchoscopy infection)
5. Superior vena cava obstruction (danger of
inducing laryngeal edema)
Poor patient cooperation, hypoxemia with an
arterial Po 2 that cannot be increased to 60 to 65 torr
with supplemental oxygen, uncorrected bleeding diathesis, acute respiratory acidosis of a ny degree, dangerous cardiac arrhythmias, recent (within six weeks)
acute myocardial infarction, and untreated active
pulmonary tuberculosis are contraindications for fiberoptic bronchoscopy. Terminally ill a nd aged patients with unstable vital signs should not have fiber169
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optic bronchoscopy performed. Severe pulmonary
hypertension and poor cardiopulmonary reserve are
relative contraindications.
Physician and Patient Preparations for Fiberoptic
Bronchoscopy
Prior to bronchoscopy, the endoscopist should
perform a history and physical examination, review
the chest radiographs, electrocardiograms, and blood
and urine tests . Arterial blood gas and spirometric
studies should be performed , if possible, prior to the
procedure. Coagulation studies (prothrombin time,
partial thromboplastin time, platelet count) should
be obtained. Three sputum smears for acid-fast organisms shouid be obtained in patients whose chest
radiographs are consistent with a diagnosis of tu~
berculosis. Finally, a signed operative permit should
be obtained from the patient.
Oxygen prophylaxis. All patients should receive
supplemental ,'oxygen administered by nasal catheter
or cannula 5 L/ min . The Pao 2 may decrease as much
as 20 torr during and for several hours after bronchoscopy .4 This drop in oxygen tension appears to be
the result of multiple factors, including partial or
complete obstruction of the airways, filling of alveolar spaces with lavage or anesthetic solutions, and
suctioning. Therefore, all patients who have a reduced Pao 2 prior to the procedure should be given
supplemental oxygen for six to ten hours following
bronchoscopy.
Cardiac monitor. It is desirable that all patients
should have cardiac monitoring during bronchoscopy. The sudden development of an arrhythmia
or change in cardiac rate may suggest hypoxemia .
Recent studies suggest that fiberoptic bronchoscopy
does not consistently enhance preexisting ectopic
beats in patients with ischemic heart disease, therefore, the procedure is not contraindicated in patients
with stable angina. However, patients with coronary
heart disease should be monitored closely during the
procedure, since sinus tachycardia can develop,
which may cause ischemic events thus precipitating
arrhythmias.• The most important factor in the development of arrhythmias is not bronchoscopy itself,
but rather the underlying cardiopulmonary status of
the patient.
Preoperative orders. For a morning procedure,
NPO after midnight is required; for an afternoon
procedure, only a light liquid breakfast may be given .
Atropine 0.8 to 1.0 mg is given intramuscularly 30
minutes before bronchoscopy since this drug blocks
vasovagal reflexes and also reduces the amount of
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bronchial secretions. Depending upon the age, size
and clinical condition of the patient, morphine 7 .5 to
15 mg or meperidine 50 to JOO mg may be given
intramuscularly with the atropine. In our institution
we commonly use codeine 60 mg and atropine 0.8 to
1.0 mg 30 minutes prior to bronchoscopy. Patients
with severely reduced pulmonary function are given
only atropine.
Topical anesthesia is an extremely important
factor in securing patient acceptance and performing
a successful bronchoscopic examination. Lidocaine is
the most commonly used agent as it is effective and
safe provided a maximum dosage of 600 mg is not
exceeded during the procedure. This dose, which is
larger than that usually recommended, has been
found safe in a large series. In patients with severe
liver disease or congestive heart failure no more than
300 mg should be given.
The patient is first instructed to gargle with approximately 4 ml of 4% lidocaine for one to two
minutes, followed by spraying of the oropharynx and
the most widely patent nostril with 5 ml of 4% lidocaine via a #15 DeVilbus atomizer. Cotton balls
soaked in 4% lidocaine are applied to each piriform
sinus for one minute; then , via a curved cannula, 2.0
ml of I% lidocaine is administered over the vocal
cords.
With the patient either seated or supine the flex~
ible fiberoptic bronchoscope can be passed (with or
without an endotracheal tube) either transnasally or
transorally . The most commonly used technique for
diagnostic study in the United States is the direct
transnasal passage. (If fiberoptic bronchoscopy is
carried out through an endotracheal tube, the internal diameter of the tube should be 8.5 mm). The
distal six inches of the fiberoptic bronchoscope is
lubriCated with lidocaine jelly. The bronchoscope is
then passed through the nostril and when in the
oropharynx, the tip angulated anteriorly to view the
larynx. If the patient begins coughing, 2 ml of 1%
lidocaine is administered over the vocal cords. The
patient is instructed to take a deep breath, and the
bronchoscope is passed into the trachea during this
inspiration. Additional small amounts of I% lidocaine are given as necessary to suppress coughing.
Once the bronchoscope is in the tracheobronchial
tree, examination of all five lobes can be performed in
approximately 10 to 15 minutes .
Biopsy Technique
A variety of biopsy instruments, primarily
brushes and forceps, are available for diagnosis of
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pulmonary lesions. In general, both brushes and forceps are used for all lesions. The brush biopsy is
obtained by moving the brush briskly back and forth
over the suspicious area. If the bronchoscope has
been introduced through the endotracheal tube, after
each biopsy, the brush is pulled back just inside the
bronchoscope and the bronchoscope removed from
the tracheobronchial tree. The brush is then advanced forward and smears are made on glass slides
which are placed in 95% alcohol.
Forceps biopsy can be used in the diagnosis of
local or diffuse pulmonary lesions. In diffuse lung
disease, the forceps is introduced into a small peripheral airway, usually in a lower lobe segment. The
forceps is opened in inspiration, the patient is instructed to exhale completely, the forceps is advanced
slowly about I cm, and at the end of an exhalation
the biopsy obtained. Following the removal of the
forceps, the distal end of the bronchoscope should be
wedged into the bronchial segment for one minute to
prevent possible bleeding. The biopsy specimen is
placed in a sterile tube filled with Ringer solution. In
general, three to four specimens, sometimes as many
as six to eight, are taken . Bronchial washings with IO
to 20 ml saline solution should also be obtained. The
specimens should be sent for cytology, smears, a nd
cultures for acid-fast organisms, fungi, and pathogenic organisms.
It is desirable to perform transbronchial biopsy
under fluoroscopic control if available. Because of
the possibility of bilateral pneumothorax, biopsies
are taken from one lung only.
In localized disease the forceps is introduced to
the lung lesion, then withdrawn I cm, opened, then
advanced until it touches the lesion; the forceps is
closed and the biopsy obtained. Prior to brush or
forceps biopsy, administration of 5 ml boluses of
I: 20,000 epinephrine over visible tumors or into distal airways (in cases of diffuse lesions) before biopsy,
reduces the incidence of pulmonary hemorrhage. A
total of 20 ml of I : 20,000 epinephrine solution can be
given over a period of 20 minutes, except in patients
with severe hypertension and serious arrhythmias. In
patients with uremia, brush or forceps biopsies
should not be done because of the possibility of severe hemorrhage; in those with a platelet count of less
than 50,000/ mm, 3 six to ten platelet packs should be
infused just prior to bronchoscopy. Finally, patients
with bronchial asthma are prone to develop severe
bronchospasm. They should be given bronchodilators and probably steroids prior to bronchoscopy.
Where centrally located visible carcinoma of the
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lung is present, the incidence of positive forceps
biopsy is about 97%. The overall yield in peripheral
carcinoma of the lung is about 60% to 70%, in metastatic carcinoma of the lung, about 30% to 40%, and
in diffuse lung diseases, the diagnostic yield ranges
from 62% to 79%. In stage I sarcoidosis, transbronchial biopsy will confirm the diagnosis in 50% to
60% of cases while in stage II and stage III sarcoidosis, diagnostic success is about 90%.
Complications of Fiberoptic Bronchoscopy
The overall complication rate is approximately
8%. The mortality rate is 0.1 %. The following are
potential complications:
I. Hypoxemia
2. Laryngospasm
3. Hemorrhage
4. Pneumothorax
5. Bronchospasm
6. Cardiac arrhythmias and acute myocardial
infarction
7. Post-bronchoscopy infection
8. Trauma due to endotracheal tube insertion
9. Hypoventilation

In summary, fiberoptic bronchoscopy is an extremely useful technique in the diagnosis and management of pulmonary diseases. It is quite safe and
comfortable for the patient and it permits examination of airways previously inaccessible to the endoscopist. However, physicians must evaluate each patient carefully. The procedure should be performed
by an experienced endoscopist who is familiar with
risk factors and proper indications for fiberoptic
bronchoscopy.
REFERENCES
I. GRILLO IA: Pulmonary endoscopy: From Killian to Ikeda, a
historical appraisal. J Jap Bronch-esophago Soc 22:107-111,
1971.

2. ZAVALA DC: Flexible Fiberoptic Bronchoscopy: A Training
Handbook. Publication Order Department, University of Iowa,
Iowa City, 1978.
3. ZAVALA DC: Pulmonary hemorrhage in fiberoptic transbronchial biopsy. Chest 70:584-588, 1976.
4. PIERSON DJ, !SEMAN MD, SUTTON FD, ET AL: Arterial blood
gas changes in fibertoptic bronchoscopy during mechanical
ventilation. Chest 66:495-497, 1974.
5. LUCK JC, MESSEDER OH, RUBENSTEIN MJ, ET AL: Arrhythmias
from fiberoptic bronchoscopy. Chest 74: 139-143, 1978.

Bedside Flow-Directed Balloon
Catheterization in the Critically Ill Patient
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Prior to 1970, catheterization of the right heart
and pulmonary artery required the use of fluoroscopic guidance and was only performed in specialized research units and/ or the cardiac catheterization
laboratory. The need to assess the hemodynamic
status of the left atrium and ventricle on a continuing
basis brought about the development of the flowdirected ballon-tipped catheter.' With the availability
of this tool, routine bedside right heart catheterization has become a. reality in the critical care units of
many community hospitals. This technique provides
the physician with the means for indirectly appraising
left heart hemodynamics and to gauge the effects of
various modes of therapy on tissue perfusion by monitoring the pulmonary artery and pulmonary capillary wedge pressures (PCWP), cardiac outputs, and
mixed venous Po 2 (Pvo 2 ).
Relationship Between Pulmonary Capillary Wedge
Pressure ( PCWP) and Left Ventricular End Diastolic
Pressure
The term pulmonary capillary wedge pressure
originated many years before the discovery of the
flow-directed catheter. During routine diagnostic
right heart catheterizations, it was customary to ad-
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vance the rigid catheter, under fluoroscopic guidance,
from a large pulmonary artery to a more peripheral
position. Here resistance was met within a small pulmonary artery branch whose inside diameter approximated that of the catheter. The catheter was then
forcibly advanced a short distance until it became
physically wedged. This "wedging" occluded the pulmonary artery pressure tracing and monitored the
distal or downstream pressure, that is, left heart pressures were reflected retrograde through the pulmonary capilla ries to the catheter tip. These same
pressures can now be monitored at the bedside, employing the flow-directed catheter by inflating the
balloon and temporarily obstructing pulmonary artery pressures and flow.
Since the PCWP is an indirect reflection of the
left atrial pressure, it is used as an assessment of the
left ventricular filling pressure during diastole. The
value of this measurement is important in the diagnosis and management of the critically ill patient.
Indications for Bedside Pulmonary Artery
Catheterization
Although there are no universally agreed upon ,
absolute indications for the use of the flow-directed
catheter, the following list includes many of the clinical conditions in which hemodynamic monitoring
may be useful.
MCV QUARTERLY 14(4): 172-175, 1978
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I. As a guide to fluid management
a. acute renal failure
b. acute pancreatitis
c. burn patients
2. Evaluation and management of shock states
a. septic
b. hypovolemic
c. cardiogenic
3. Diagnosis and management of respiratory failure
a. adult respiratory distress syndrome
b. primary pulmonary hypertension
c. pulmonary embolism
4. Diagnosis of cardiac dysfunction
a. cardiac tamponade
b. constrictive pericarditis
c. mitral insufficiency
d. intracardiac shunts (left to right)
5. Assessment of left ventricular function
a. acute myocardial infarction
b. congestive heart failure
c. post-open heart surgery
d . ventricular afterload reduction
Catheter Insertion
Our choice of insertion routes are the median
basilic, internal jugular, femoral, and subclavian
veins, in that order. (We are particularly hesitant to
employ the subclavian approach because of the
chance of pneumothorax which may be poorly tolerated in the critically ill patient). Percutaneous guide
wire insertion (Fig. I) is normally used, although on
rare occasions a surgical cutdown of a median basilic
vein may be necessary .
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Following introduction, the catheter tip is advanced to the intrathoracic vena cava (a distance of
35 to 40 cm from the femoral or basilic vein and 15 to
20 cm from the internal jugular insertion site) where
the balloon is then inflated with from 0.5 to 1 cc of
air. With the balloon acting as a sail, the catheter is
pushed through the right atrium and ventricle and
into the pulmonary artery (Fig. 2). The position of
the catheter tip is determined by the pressure contour
tracing monitored throughout the procedure (Fig. 3).
As the catheter tip reaches smaller caliber pulmonary
arteries, the balloon occludes the vessel, producing a
wedge pressure tracing . During catheter advancement, the electrocardiogram is carefully monitored
by the nurse assisting with the procedure. The nurse
reports the number of successive PVCs as a warning
to the physician to change the position of the catheter
tip.
Hemodynamic and Physiological Indices Derived from
Flow-directed Catheters
Pulmonary capillary wedge pressure (PC WP).
The PCWP reflects left ventricular end diastolic filling pressures in the absence of left atrial or mitral
valve dysfunction (mitral stenosis, mitral insufficiency, left atrial myxoma, and other conditions).
The normal pulmonary wedge pressure ranges from 6
to 12 mm Hg with a value greater than 12 . mm Hg,
implying either left ventricular dysfunction or fluid
overload. To differentiate these two clinical conditions, a cardiac output and / or Pvo 2 needs to be obtained . (See below) A low pu.l monary wedge pressure,
that is, below 6 mm Hg, implies "pure" intravascular
fluid depletion such as occurs with hemorrhage, or

superior
vena cavo

Fig. I-Percutaneous catheter introducer consisting of wire guide
(small arrow), dilator (double arrow) and sheath (large arrow).
This assembly is used in conjunction with a 16 gauge teflon needle.

Fig. 2-Flow-directed catheter advanced from superior vena ca va
through the heart into a branch of left pulmonary artery .
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Fig . 3-ldealized recording of pressures seen as catheter is passed from right atrium (RA), right ventri cle (RV) , a nd pulm onary a rtery
(PA); with the balloon inflated , the pulmonary wedge pressure (PWP) is obtained .

"relative" intravascular depletion as is seen in the
early stages of septic shock. Once again cardiac output or Pvo 2 determinations will help differentiate
these entities. (See below)
Cardiac output. Balloon-tipped flow-directed
catheters are available with thermodilution cardiac
output capabilities. These triple lumen catheters have
an orifice located 30 cm proximal from the tip
through which room temperature or iced saline, or
5% dextrose solutions, can be injected for the purpose
of obtaining a cardiac output.2 A thermistor bead
located near the tip of the catheter detects changes in
temperature from which cardiac outputs can be computed.
Mixed venous Po 2 ( Pvo 2 ). The flow-directed catheter also permits sampling of true mixed venous
blood (obtained from the pulmonary artery) for Po 2
and oxygen content determinations. The Pvo 2 (normal range in a nonanemic patient, 35 to 40 torr)
reflects changes in cardiac output and tissue perfusion. As tissue perfusion and / or cardiac output
decreases, the Pvo 2 decreases as peripheral tissues
extract more oxygen from the blood. For example, a
patient with a high PCWP and a normal or elevated
Pvo2 has a normal or elevated cardiac output thus
implicating fluid overload as the cause for the elevated PCWP. In a patient whose PCWP is elevated
and Pvo 2 (and thus cardiac output) is low, tissue
perfusion has been compromised due to left ventricular dysfunction. In contrast, a patient with a low
PCWP and a low mixed Pvo 2 (usually below 30 torr)
probably has "pure" intravascular fluid depletion
and will need intravenous fluids to correct the deficiency. A low PCWP and an inappropriately elevated
Pvo 2 (usually above 30 torr) is usually a sign of sepsis.
In this condition peripheral arteriovenous shunting
occurs with failure to extract oxygen at the cellular
level.
Shunt equation ( Qs / Qt). The degree of physio-

logical and/ or anatomic shunting which occurs in
patients with both cardiac and pulmonary disease(s)
can be calculated by employing the standard shunt
formula and obtaining true mixed venous oxygen
contents from the flow-directed catheter when in the
pulmonary artery position. The shunt calculation,
although somewhat cumbersome and complicated,
can be used as an index for weaning patients from
ventilators, for determining the most appropriate
level of positive end expiratory pressure (PEEP}, and
for following the improvement or deterioration in the
patient's cardiopulmonary status on a day-to-day
basis.
Complications
As with any other invasion procedure, flow-directed catheterization can be associated with complications but probably in less than I% to 2% of all
insertions. 3
I. Ventricular and atrial arrhythmias, including
ventricular tachycardia and fibrillation.
2. Pulmonary infarction
3. Ruptured cordae tendenae of the tricuspid
valve.
4. Rupture of a pulmonary artery and / or capillary
with subsequent hemorrhage
5. Infections
6. Knotting of catheters.
The Nurse's Role
The critical care nurse plays an important and
essential role during and following the catheterization. It is his or her responsibility not only to set up
and calibrate the transducers but also to assist during
the actual catheterization. The nurse must be proficient in monitoring the electrocardiogram during
catheter placement and inform the physician of any
potentially serious arrhythmias. Additionally, he or
she must be an expert in monitoring and reporting
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the pulmonary artery and pulmonary wedge pr~s
sures. Finally, the nurse must be acquainted with the
problems associated with obtaining accurate pressure
measurements and be alert to possible complications
that can occur with the flow-directed catlieter.
In summary, with the aid of the balloon-tipped
flow-diteeted catheter, we are now able to measure
pulmonary artery and pulmonary capillary wedge
pressures at the bedside. The results obtained from
pulmonary artery catheterization have added greatly
to the management of the critical ill patient.
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Intrapulmonary Lymph Node Presenting as a
'Coin' Lesion: A Case Report
SIBU P. SAHA, M .D .
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Intrapulmonary lymph node seldom presents as
a solitary pulmonary nodule. This rare clinical entity
is reported in the following case:
Case Report
A 40-year-old woman was evaluated because of
the radiological finding of a noncalcified, noncavitary, solitary, pulmonary nodule. She was asymptomatic at the time of examination. The patient's past
history included hiatal hernia, duodenal ulcer, and
recurrent supraventricular tachycardia. She has habitually smoked one pack of cigarettes daily for 15
years. The physical examination was unremarkable
except for mlld obesity.
A round density in the right infrahilar area was
found in chest roentgenogram, which was not present
in previous films. Tomographic examination showed
a smooth mass without cavitation and calcification
(Figure).
Bronchoscopic examination was normal and the
patient underwent exploratory right thoracotomy. A
firm , smooth mass was located in the anteromedial
segment of the right lower lobe. A vertical incision
was made directly over the lesion to a depth of approximately 2 cm through the lung tissue. The exposed nodule was completely excised and reported as
benign intrapulmonary lymph node. The postoperative course was uneventful.
Correspondence and reprint requests to Dr. Sibu P. Saha,
2121 Nicholasville Road , Lexington , KY 40503.
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Discussion
An intrapulmonary lymph node large enough to
present as a "coin" lesion on chest x-ray is rare.
Steele' reported only four such cases in 887 resected
solitary pulmonary nodules. Lymph nodes are normally . found around the main bronchi and its lobar
branches, usually extending only as far as the third or
fourth divisions. Only aggregations of lymphoid tissue are found beyond this point. According to Trapnell,2 Mill er believed that the intrapulmonary lymph
nodes developed in abnormal lung from lymphoid
tissue. The lymphoid tissue in lungs wou.ld increase
with age, probably in response to inhaled carbon
particles or infections. Trapnell in his study of 92
postmortem lungs found six cases of intrapulmonary .
lymph node and concluded that "such nodes are not
nearly so uncommon as is suggested by the literature." Greenberg3 reported a case of subpleural
lymph node in 1961. This was a hyperplastic lymph
node caused by anthracotic pa rticles. A similar case
has been reported by Rosenthal a nd his associates.4
Exploratory thoracotomy followed by resection
continues to be the most commonly used method in
the diagnosis and treatment of a solitary pulmonary
nodule.

Summary
A case of intrapulmonary lymph node presenting as a solitary pulmonary nodule is presented with a
brief discussion .
MCV QUARTERLY 14(4): 176-177, 1978
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Figure-Tomogram of a noncavitary, noncalcified intrapulmonary mass.
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Maxillary Periapical Actinomycosis: A Case
with an Unusual Roentgenographic
Appearance
DANNY R. SAWYER, D.D.S., PH.D.

Department of Oral Surgery and Pathology, Lagos University Teaching Hospital, C.M. UL. , Lagos, Nigeria
DENNIS G. PAGE, D.D.S., M.S .

Department of Oral Pathology, Medical College of Virginia, Richmond, Virginia

Actinomycosis was once a fairly common disease and one that has a long history . "It was undoubtedly observed early in the 19th Century, as
actinomycotic lesions were described erroneously in
1826 by LeBlanc as osteosarcomas and later in the
1800s Bollinger (1876) first recognized it as a specific
entity which he named 'lumpy jaw.' " 1 The most frequent clinical form of actinomycosis is the cervicofacial type which is seen in 60% of reported cases, the
other forms being abdominal (20% ), pulmonary
(15%), and cutaneous (5%). 2 Young adult males are
most frequently affected with actinomycosis .3 The
actinomycetes, the so-called "higher" bacteria, are
among the more common microorganisms found
within the oral cavity'; however, they seldom exist as
pathogens within the oral cavity, and Goldstein et al
(1972) 5 report that there are fewer than 50 cases of
actinomycosis of the maxilla reported in the English
literature. Periapical actinomycosis is seen even less
frequently . Browne and O'Riordan 6 reported a case
of periapical actinomycotic granuloma and found
that only ten such cases were on record before 1966.
In 1975 Samanta et aF reported that the analysis of
cases reported subsequently to those of Browne and
O'Riordan revealed only five additional cases in

Correspondence and reprint requests to Dr. Dennis
Page, Department of Oral Pathology, Box 637, Medical
College of Virgini a, Richmond, VA 23298.
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which colonies of actinomycetes were demonstrated
on histologic studies of the periapical tissue.
The diagnosis of actinoniycosis may be accomplished by several means. While a direct smear of the
pus and identification of the sulfur granules are suggestive of actinomycosis , anaerobic culture or histologic evidence, or both, are considered diagnostic.
The roeiltgenographic appearance of cervicofacial actinomycosis is not diagnostic, although chronicity
and a relative lack of bone reaction are suggestive.a
The appearance may vary from one of lytic destruction without bone formation to one of a definite
thickening and sclerosis.a The most common appearance of maxillary actinomycosis is a localized radiolucent periapical or periodontal abscess in a healthy
adult who shows no signs of systemic toxicity.• In
distinction to mandibular actinomycosis, cutaneous
fistulas or hard facial swellings are unusual in the
maxillary form of the disease. Antral-facial fistulas as
well as oral-antral fistulas have been noted from maxillary molar extraction sites. Intraoral mucosa) drainage occurs much more frequently with maxillary actinomycosis than with the mandibular form of the
disease. Oral trauma or a preexisting condition is a
common feature of maxillary actinomycosis.
This paper describes a case of the rare form of
maxillary periapical actinomycosis with a bizarre
roentgenographic appearance. The clinical signs and
symptoms along with the roentgenographic appearance of this lesion were not suggestive of actiMCV QUARTERLY 14(4):178-180, 1978
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Fig 1-Radiograph showing biza rre periapical lesion . Note
"soapbubble" appearance.

Fig 3-Histologic sect io n showing actinomycotic granule
surrounded by sea of polymorphonuclear leukocytes. (H &
E, 200 X )

nomycosis and thus were not included within the
clinical differential diagnosis.

sectioned soft tissue mass co mposed of granulomatous fibrous connective tissue containing areas
of central abscess formation from which radiating
hyphae-like structures showing the characteristic eosinophilic " clubs" were seen (Fig 2). These "granules" appeared to be floating in a sea of polymorphonuclear leukocytes associated with an occasional
macrophage and multinucleated giant cell (Fig 3). On
the surface of this lesion severa l organisms having
budding yeast-like forms scattered along pseudohyphae were noted (Fig 4). Pathologic diagnosis
based on histologic examination with special stains
was a mixed infection of actinomycosis and a superficial candidosis.
Following su rgical removal of the lesion and

Case Report
A 33-year-old white female consulted her private
practitioner, and upon radiographic examination, a
radiolucent lesion associated with the apex of the
upper left first molar was discovered (Fig I). Questioning revealed that the lesion had been present for
over three years during which ti me the patient had
not sought treatment. Clinically, friable brownish tissue with multiple root fragments was surgically removed by excisional biopsy and sent to the laboratory for histologic examination .
Histologic ·examination revealed a multi-

I

Z.'i">'· ?'

tt

Fig 2-Histologic section showing typical actinomycotic
"granule." (Mallory's Gram method , 400 X )

l

Fig 4-Histologic section showing pseudohyphae of Candida on surface of actin omycotic granule. (Mallory' s Gram
method, 400 X )
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need for recourse to prolonged antibiotic therapy
whenever surgical intervention alone can totally eradicate the infected focus . This case substantiates this
claim.
Summary

An unusual case of maxillary periapical actinomycosis presenting with a bizarre roentgenographic appearance is presented. Local surgical eradication coupled with short-term drug therapy resulted
in the complete resolution of the lesion.

Fig 5-Follow-up radiograph showing resolution and healing of site of localized lesion.
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histologic diagnosis of the tissue, the patient's local
practitioner began treatment with Penicillin V-K, 250
mg tablets four times per day for twenty days and
nystatin (Mycostatin) (500,000 units), I tablet three
times per day. Systemic involvement of the disease
was ruled out by medical examination. One year following treatment, roentgenographs of the area
showed complete resolution of the lesion (Fig 5).
Discussion
The unique feature of this case is the bizarre
radiographic appearance of the lesion. In contrast to
the normal localized radiolucent periapical lesion of
maxillary peria,pical actinomycosis, this lesion appeared radiographically as a multilocular lesion
("soap bubble" appearance) more characteristic in
this region of a giant cell granuloma, myxoma, or
brown tumor of hyperparathyroidism.
Clinicians often associate actinomycosis with the
more florid soft-tissue cervicofacial type and this is
obviously not always found owing to the localization
of maxillary lesions which tend to remain asymptomatic.
In terms of treatment in maxillary periapical
lesions, Stenhouse 3 notes that there appears to be no
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The Dental Health Status of Pre-Columbian
Peruvians: A Study of Dental Caries, Missing
Teeth, Attrition, Osteitis, Calculus, and Bone
Loss
DANNY R. SA WYER, D.D.S., PH.D.
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Prior to the recent reports of Sawyer et al1 and
Elzay et al 2 on the characteristics and dental health
status of ancient Peruvian cultures, only Stewart3 ,
Leigh4, and Goaz and Miller5 had reported on the
dental morphology and pathology of the pre-Columbian Peruvian Indians. The purpose of this study is to
evaluate the dental health of these ancient peoples to
further our understanding of the development of dental diseases. This paper follows up and expands the
report of Elzay et al2 to include another culture and
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completely new specimens, with a look at primary
dentitions not previously available for study.
Materials and Methods
The permanent maxillae from 115 individuals,
and 113 permanent mandibles along with 46 individual primary maxillae and their primary mandibles,
separated by cultural groups, were included in this
survey. Only four specimens were found which had a
mixed dentition and these were not included in this
study. Thus, those maxillae and mandibles labeled
permanent had only permanent dentitions and those
labeled primary had only primary dentitions. All examinations were completed by gross examination of
materials with dental probes and explorers under op-
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timal light. A dental radiographic unit was available
and x-rays were used to confirm diagnoses.
The only teeth counted as missing were those
apparently lost prior to death as shown by osseous
healing in the edentulous area. Third molars were
considered congenitally absent if there was no evidence of previous tooth loss and subsequent repair,
or if they did not show on x-ray or were not grossly
present. If the third molar crown appeared within the
bone but had not completely erupted, the tooth was
classified as either semi- or unerupted.
Attrition or abrasion with no gross loss of crown
enamel was scored as O; the tooth was scored as I if
enamel loss on the cusp tips did not involve the
grooves and fissures, as 2 if the enamel loss involved
the grooves and fissures, and as 3 if the process eliminated the grooves and fissures on the occlusal surface.
This system differs from the Attrition Index of Lavelle6 only in omitting a fourth category for teeth
having pulp exposure from attrition and in recording
the highest score (most severe) noted on the specimen
in lieu of individual scores for all teeth of the specimen.
The incidence of dental caries was recorded in
two ways. First, caries were recorded according to the
DMFS (decayed, missing, filled surfaces) index. If a
tooth had a carious lesion involving only one of its
five surfaces, that is, mesial, distal, buccal, lingual
and occlusal (incisal), it was scored as I. A missing
tooth (antemortem) or one with all five surfaces
carious received a score of 5. This system denotes
severity of disease whereas reporting the percent of
teeth affected reports only the caries rate. The second
method of recording specimens was a modification of
the DMFS index. While most teeth today are lost as a
result of dental caries, teeth may have been lost in
ancient times through trauma, periodontal disease, or
pulpitis from severe attrition. Hardwick 7 developed a
method, attempting to correct this; however, it is
more meaningful to express caries incidence by omitting missing teeth. Hence, dental caries involvement
is expressed as OS (decayed tooth surfaces) per tooth
and jaw (specimen).
The condition of osteitis was recorded as present
or absent only. Gross evidence of either bone destruction and/or proliferation with or without a fistulous
tract was recorded as osteitis.
The degree of calculus formation was indicated
as light if less than I mm of calculus was deposited on
the lingual surfaces of the anterior teeth, moderate if
concomitant deposition around posterior teeth was

less than I mm, and heavy if calculus deposition on
anterior or posterior teeth exceeded I mm.
Bone loss was recorded on a scale of 0 for no
gross evidence, 1 for interdental bone loss between
adjacent teeth, 2 for bone loss down to the bifurcation area of the roots, and 3 for bone loss beyond the
bifurcation area. In any one jaw specimen only the
most severe manifestation of bone loss was recorded.
Results
The results for the permanent dentitions and
jaws are tabulated in Tables 1, 2 and 3, while the
results for the primary dentitions and jaws are tabulated in Tables 4, 5 and 6. Individuals from the lea
culture and the Paracas culture (Table 1) exhibited
the highest incidence of missing teeth in the maxillary
arch, those from the Colonial culture showed the
highest incidence of missing teeth in the mandible.
The N azca culture Indians followed by those of the
H uari culture showed the fewest missing teeth in both
arches. The lea and Paracas culture Indians showed
the highest incidence of missing first, second, and
third molars in the maxillary arch while the Paracas
and Colonial culture Indians had the highest incidence of missing first, second, and third mandibular
molars. Individuals from the Paracas culture followed by those from the Colonial culture showed the
highest incidence of congenitally missing third molars
in both arches.
The Paracas, lea and Colonial Indians had the
highest incidence of dental caries in both arches in the
permanent dentitions (Table 2). Nazca culture indians showed a low incidence of dental caries while
the Incas showed the lowest of all. In individuals witfi
the permanent dentitions, those from the Nazca and
Inca cultures had the highest incidence of osteitis in
the two arches. The Paracas, lea and Colonial Indians had the highest degree of moderate and heavy
calculus. While there is little difference in the degree
of bone loss in the six cultures, the Paracas Indians
showed a somewhat higher degree of loss.
With regard to primary arches and dentitions,
the only antemortem tooth losses were one tooth in
the maxillae in the Colonial individuals and two teeth
lost from the mandibular arches of the those from the
lea culture (Table 4). No first or second molars of
either arch were lost in these specimens and there
were no congenitally missing teeth. As with the permanent dentitions, the Paracas, lea and Colonial Indians had the highest incidence of dental caries in
both arches (Table 5). Individuals from these three
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TABLE 1
Frequency of Missing or Unerupted Teeth in the Pernianent Dentitions
M3

TEETH LOST
CULTURE
Paracas
maxillary
mandibular
Nazca
maxillary
mandibular
Huaii
maxillary
mandibular
lea
maxillary
mandibular
Inca
maxillary
mandibular
Colonial
maxillary
mandibular
Average
maxillary
mandibular

NTP

%
MISSING

%
CoNGEN!TALLY
MISSI NG

%
MOLAR I MOLAR 2
WITH SEMI%
%
OR
UN ERUPTED LACKING LACKING

N

NTP

NUMBER

%

X TEETH
LOST PER
JAW

46
31

736
496

IOI
64

13 .7
12.9

2.2
2.1

92
62

18 .5
19.4

5.5
4.9

17.4
24.2

19.6
35.5

18.5
37.1

9
20

144
320

10
30

6.9
9.4

I. I
1.5

18
40

I I. I
12.5

0.0
0.0

22.2
10.0

I I. I
15.0

16.7
22.5

13
14

208
224

19
23

9. 1
10.3

1.5
1.6

26
28

11.5
7.1

0.0
0.0

23.1
3.6

19.2
28.6

15.4
21.4

24
25

384
400

56
52

14.6
13.0

2.3
2. 1

48
50

18.8
16.0

2. 1
4.0

27.1
24.0

20.8
34.0

33.3
32.0

20
19

320
304

42
42

13.1
13 .8

2.1
2.2

40
38

12.5
10.5

0.0
0.0

57.7
47.4

2.5
5.3

2.5
5.3

20
21

320
336

33
55

10.3
16.4

1.7
2.6

40
42

10.0
19.0

5.0
4.8

5.0
7.1

17.5
47.6

7.5
35 .7

22.0
21.7

352.0
346.7

43.5
44.3

11.28
12.63

1.82
2.02

44.0
43.3

13.73
14.08

2.10
2."28

25.38
19.38

15.12
27.67

15.65
25.68

N = number of jaw specimens
NTP = number of teeth possible
X = mean

cultures also showed (Table 6) the highest incidence
of osteitis and the highest degree of moderate and
heavy calculus. The Paracas culture Indians showed a
slightly higher degree of bone loss in the arch than the
other cultures, but this difference is not significant.
Discussion
The results indicate that in the permanent dentitions the Paracas, lea and Colonial individuals have
the highest incidence of missing antemortem teeth
while in the primary dentitions only the lea and Colonial cultures have specimens showing tooth loss . The
Nazca and Huari permanent dentitions exhibit the
lowest incidence of antemortem tooth loss . These
findings parallel dental caries incidence, as the Paracas, lea and Colonial Indians have the highest incidence of dental caries in both the permanent and
primary dentitions. The incidence of antemortem
tooth loss has been reported to decline spectacularly
with the transition to an agricultural society, from

41.6% loss in early hunting and gathering economies
to 6.2% in the most recent phases.8 These pre-Columbian cultures were primarily agricultural societies.
Average tooth loss in the permanent dentitions was
11.3% in the maxillary arch and 12.6% in the mandibular arch. Iri our earlier study 2 consisting of 101
mandibles, an 18.6% antemortem loss was found. The
tabulated findings on antemortem tooth loss in ten
prehistoric adult populations show a 19.9% loss for
Gran Canaria.9 The Inca individuals showed the
highest incidence of semi- or unerupted third molars.
This group also had low scores for caries, bone loss,
and calculus, suggesting that although the sample
was an adult population, it was a younger age group
than the other cultures. (This was later confirmed by
age analysis.)
The Paracas, Colonial and lea Indians showed
evidence of congenitally missing third molars. The
Paracas individuals showed the highest incidence of
congenitally missing third molars in both arches,
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beirig 5.~ % in the maxillae and 4.9% in the mandible.
The Nazca, Huari and Inca Indians showed no specimen with congenitally missing teeth among those
stud\~d. The average for all six cultures was 2.1o/o for
ihe rµaxillae third molars and 2.3 % for the mandibular third molars.
While at least one of the cultures consisted of
young adults, the incidence of third molar hypodontia was 15.8% (including those that were congenitally missing) for the maxillary arches and 16.4%
(including the congenitally missing) for the mandibular arches. Carbonell' 0 reported a 2.6% incidence of
third tnolar hypodontia (mandibles only) in the Kish
of Mespotania (3000 B.C.) while Crispim et al 11 reported 8% per quadrant and 2% for all four third
molars in a trihybrid Brazilian population. Niswander12 reported a 30.5% incidence of one or more missing third molars in the Xavante Indians of Brazil, and
Dahlberg 13 indicated that Mongoloid people have a
higher percentage of agenesis of third molars than do
other groups. Our earlier data 2 showed a third molar
hypodontia of 3.6% in IOI mandibles. The present

data more clearly confii".nis what one would expect in
a population of Mongoloid background. An obvious
difficulty in comparison of available data is the lack
of uniformity in reporting results .
Our findings on attrition indicate that the six
pre-Columbian cultures had moderate attrition and
no resulting pulp exposures. Occlusal wear pattern
was not noticeably oblique as noted in cultt1r~s where
teeth are used to strip husk or bark from a food
sourc~. It would appear that the cultures shared a
similar diet in terms of consistency and / or preparation. Previous reports 3·4 ori pre-Columbian Peruvians
also found no severe attrition or pulp involvement.
Similarly, Carbonell 14 found no pulp involvement
from attrition in ancient Mesopotamians. Although
the data on partially erupted third molars suggest
that the Inca specimens are of younger age, these
individuals still had attrition effects similar to the
specimens of the other cultures.
Results of dental caries have meaning only when
comparisons are made among the cultures observed.
While lower age may cause the low caries in the Inca

a

TABLE 2
Frequency and Severity of Attrition and Dental Caries in the Permanent Dentitions

X SCOR E
OF ATTRITION
CULTUR E
Paracas
m ~x ill ary
mandibul ar
Nazca
maxill ary
mandibul ar
Huari
maxill ary
mandibular
ica
maxill ary
mandibul ar
Inca
maxill ary
mandibular
Coloriial
maxiilary
manaibular
Average
maxilhiry
mandibul ar

CARIES BAS ED ON OMFS

CARI ES BASED ON OS

x OS / TOOTH

x OS / JAW

19.20
22.90

1.08
1.16

8.02
11.50

1.02
1.03

11.56
13.65

0.43
0.47

4.89
6.15

142
174

1.37
1.25

15.00
10.79

0.70
0.59

7.69
7.36

1.9
2.2

294
296

1.96
1.97

24.04
21.72

1.01
1.01

12.38
11.32

20
19

1.8
1.9

316
302

0.22
0.24

3.55
3.74

o.m
0.04

0.55
0.58

20
21

2.1
2.1

295
306

1.66
1.82

24.45
26.48

1.15
0.87

16.95
12.67

15.2
21.5

1.88
2.03

263.8
284.0

1.410
1.435

16.300
16.547

0.733
0.690

N

0, I, 2, 3

TNT

45
30

1.8
1.9

434
362

2.23
2.30

9
20

2.1
2.2

102
264

13
14

1.6
1.9

24
25

N = number of jaw specimens
TNT = total number of teeth
X = mean
OMFS = decayed , missing, filled tooth surfaces
OS = decayed surfaces

X OMFS/ rnoTH X OMFS / JAW

8.413
8.263
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TA BLE 3
Frequency and Severity of Osteitis, Calculus and Bone Loss in the Permanent Dentitions
0STEIT!S
CULTUR E
Paracas
maxi ll ary
mandib ular
Nazca
maxi ll ary
mandibular
Hu ari
maxi ll ary
mandibul ar
lea
maxi ll ary
mandibular
Inca
maxillary
mandibular
Co lonial
maxillary
ma ndibular
Average
maxi ll ary
mand ibul ar

CALCU LUS % AFF ECTED

BONE Loss

N

% AFFE CTED

N

LIGHT

MOD ERATE

HEAVY

N

X SCOR E 0, 1,2,3

46
31

32.6
38 .7

45
30

30.0
23 .3

50.0
50.0

20.0
26.7

46
31

1.8
2.0

9
20

44.4
45.0

9
20

87.5
83.3

12.5
5.6

0.0

I I.I

9
20

1.7
1. 5

13
14

15 .3
14.2

13
14

83.4
83.4

16.6
8.3

0.0
8.3

13
14

I. I
1.2

24
25

16.7
20.0

24
25

33 .3
35 .0

44.5
40.0

22.2
25.0

24
25

1.3

20
19

33 .0
50.0

20
19

33. .3
50.0

66.7
50.0

0.0
0.0

20
19

1.2
1.3

20
21

20.Q
23.8

20
21

40.0
57.0

40.0
21.5

20.0
21.5

20
21

1.4
1.3

22.0
21.7

27.00
3 1.95

15.2
2 1. 5

5 1.25
55 .34

38 .38
29.23

10 .37
15.43

22.0
21.7

1.42
1.43

l.J

N = number of jaw specimens
X = mean
TABLE 4
Frequency of Missing or Unerupted Teeth in the Primary Dentitions
TEETH LOST
CULTURE
Paracas
maxi ll ary
mandibular
Nazca
maxillary
mandiqu lar
Huari
max ill ary
mand ibu lar
(ca
maxillary
mandibu lar
Inca
maxillary
mandibu lar
Colonial
max ill ary
mand ibu lar
Average
maxillary
mandib ular

%
CONGEN ITALLY
MISS ING

MOLAR I

MOLAK2

LACKI NG

LA CKING

N

NTP

NUMB ER

%

X T EETH
LOST PER JAW

9
6

90
60

0
0

0.0
0.0

0.0
0 .0

0.0
0.0

0.0
0.0

Q.O
0.0

2
2

20
20

0
0

0.0
0.0

0 .0
0.0

0.0
0.0

0 .0
0.0

0.0
0.0

4
3

40
30

0
0

0.0
0.0

0.0
0.0

0.0
0.0

0.0
0.0

o.6

14
15

140
150

0
2

0.0
1.3

0 .0
0. 13

0.0
0.0

0.0
0.0

0.0
0.0

2
3

20
30

0
0

0.0
0 .0

0.0
0.0

0.0
0.0

0.0
0.0

0.0
0.0

15
16

150
160

I
0

0 .7
0 .0

0.06
0.0

0.0
0.0

0.0
0.0

9.0

0.16
0.33

0 . 12
0.22

0.0 1
0.02

0.0

0.0
0 .0

0.0
0.0

7.7
7.5

N = number of jaw specimens
NTP = number of teeth possib le
X = mea n

76.7
75 .0

o.6

0.0

o:o
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TABLE 5
Frequency and Severity of Attrition and Dental Caries in the Primary Dentitions

CARIES BASED ON OMFS

X SCORE
OF ATTRITION
CULTURE
Paracas
maxillary
mandibular
Nazca
maxillary
mandibular
Huari
maxillary
mandibular
lea
maxillary
mandibular
Inca
maxillary
mandibular
Colonial
maxillary
mandibular
Average
maxillary
mandibular

CARIES BASED ON OS

x OS / TOOTH

x OS / JAW

4.1
3.2

0.49
0.35

4.1
3.6

0.21

2.0

0.21

2.0

34
24

0.47
0.17

4.0
1.3

0.47
0.17

4.0
1.3

1.7
1.6

105
123

0.47
0.33

3.5
2.7

0.47
0.25

3.5
2.1

2
3

1.0
0.8

JO
28

0.10
0.00

0.5
0.0

0. JO
0.00

0.5
0.0

15
16

1.2
I. I

115
128

0.55
0.36

4.2
2.9

0.50
0.36

3.9
2.9

0.382
0.242

3.05
2.02

0.373
0.226

3.00
1.98

N

0, 1,2,3

TNT

9
6

1.5
1.3

76
54

0.49
0.35

2

1.3

19

4
3

1.5
1.6

14
15

7.7
8.6

1.37
1.28

59.8
71.4

X OMFS / TOOTH X OMFS / JAW

N = number of jaw specimens
TNT = total number of teeth
X = mean
OMFS = decayed, missing, filled tooth surfaces
OS = decayed surfaces

Indians, the reasons for different caries incidence in
the remaining groups are not as obvious. The three
groups scoring high on caries also scored highest in
calculus involvement. The Paracas, lea and Colonial
individuals who had the highest caries incidence were
all members of "coastal" as opposed to "inland"
cultures. Something in the diet or water of the "inland" people, such as fluoride, could have protected
them against caries. Further investigation on fluoride
content of bones and teeth should shed some light on
this relationship. The reason for a lower incidence of
caries in the Nazca individuals, also a "coastal"
group, is not readily apparent.
The maxillae are more frequently involved with
caries than the mandible. 15 In the present study this
was noted using both the incidence of caries based on
DMFS and on OS in primary dentitions. The maxillae were shown to be more frequently involved with
caries using the DS index in the permanent dentitions, but because of the large number of mi~sing
teeth (antemortem) in the mandibles of the per-

manent dentitions, the DMFS showed the incidence
of caries to be about equal in the two arches. Because
of the method of scoring using the DMFS index, this
can be considered a misleading value and again the
maxillae showed a higher incidence of caries. In this
study, using optimal gross examination coupled with
roentgenographic analysis, 26.7% of the individuals
with primary dentitions and 85.2% of the individuals
with permanent dentitions had one or more carious
lesions. In our earlier study 2 70% of the permanent
mandibles had one or more carious lesions. Leigh 4
reported a 35% incidence in specimens having both
jaws. Although the reason is still not evident, the high
incidence of caries has now been shown to be consistent in our two studies and in fact increased because
of the inclusion in this present study of maxillae
having a higher incidence of dental caries. The caries
incidence in the combined adult population in the
United States as of 1962 was 20.4 DMFS teeth per
person. 16 The overall average of DMFS per specimen
in our earlier pre-Columbian study 2 was 13.76 in IOI
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TABLE 6
Frequency and Severity of Osteitis, Calculus and Bone Loss in the Primary Dentitions

CALCULUS o/o AFFECTED

0STEITIS
CULTURE
Paracas
maxillary
mandibular
Nazca
maxillary
mandibular
Huari
maxillary
mandibular
lea
maxillary
mandibular
Inca
maxillary
mandibular
Colonial
maxillary
mandibular
Average
maxillary
mandibular
N
X

=
=

BONE Loss

LIGHT

MODERATE

HEAVY

9
6

37.5
40.0

50.0
40.0

12.5
20.0

9
6

1.5
1.7

0.0
0.0

2

50.0

50.0

0.0

2
2

1.5
1.5

4
3

0.0
0.0

4
3

66.7
50.0

33.3
50.0

0.0
0.0

4
3

1.0
1.2

14
15

7.1
6.7

14
15

46.2
50.0

46.2
35.7

7.6
14.3

14
15

1.2
I.I

2
3

0.0
0.0

2
3

50.0
66.7

50.0
33.3

0.0
0.0

2

1.2
1.3

15
16

6.7
12.5

15
16

6.7
12.5

93 .3
87.5

0.0
0.0

15
16

1.3
1.4

42.85
43.84

53 .80
49.30

3.35
6.86

N

% AFFECTED

9
6

I I. I
16.7

2
2

7.7
7.5

4.15
5.98

N

7.7
8.6

N

7.7
7.5

X SCORE 0, I ,2,3

1.27
1.37

number of jaw specimens
mean

permanent mandibles. In the present study the average DMFS was 16.3 per maxillary specimen and 16.5
per mandibular specimen. The higher DMFS per
specimen in the present study as compared to our
earlier work is no doubt related to the use of the x-ray
unit. While these figures do not correspond exactly
with those in the United States as of 1962, they are
similar, as to incidence of caries, to the present study.
Caries data on present day Peruvians are not available for comparison.
Osteitis was noted in all six cultures. The Nazca
and Inca showed the highest incidence in the arches
with permanent dentitions while the Paracas, lea and
Colonial individuals had the highest incidence in the
primary. This finding paralleled the findings on the
mean number of missing antemortem teeth while calculus accumulation appeared to relate directly to
caries incidence.
The amount of alveolar bone loss was moderate
among individuals from all cultures with those from
the Paracas culture leading the way. Bone loss did not
correlate directly with calculus or caries scores. It is
plausible that a less refined and abrasive diet caused
both moderate attrition and alveolar bone loss in all
cultures irrespective of age.
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